scispace - formally typeset
V

Valerio Chiurchiù

Researcher at Università Campus Bio-Medico

Publications -  59
Citations -  3097

Valerio Chiurchiù is an academic researcher from Università Campus Bio-Medico. The author has contributed to research in topics: Inflammation & Cannabinoid receptor. The author has an hindex of 26, co-authored 49 publications receiving 2242 citations. Previous affiliations of Valerio Chiurchiù include University of Rome Tor Vergata & University of Teramo.

Papers
More filters
Journal ArticleDOI

Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.

TL;DR: This review summarizes current knowledge on the involvement of the main classes of endogenous bioactive lipids—namely classical eicosanoids, pro-resolving lipid mediators, lysoglycerophospholipid/sphingolipids, and endocannabinoids—in the cellular and molecular mechanisms that lead to the pathogenesis of chronic disorders.
Journal ArticleDOI

Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses

TL;DR: D-series resolvins and maresin 1 modulate adaptive immune responses in human peripheral blood lymphocytes and reduce cytokine production by activated CD8+ T cells and CD4+ T helper 1 (TH1) and TH17 cells but do not modulate T cell inhibitory receptors or abrogate their capacity to proliferate.
Journal ArticleDOI

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation

TL;DR: Endocannabinoid (eCB) signaling has been shown to regulate proliferation and differentiation of mesoderm-derived hematopoietic and mesenchymal stem cells, with a key role in determining the formation of several cell types in peripheral tissues, including blood cells, adipocytes, osteoblasts/osteoclasts and epithelial cells.
Journal ArticleDOI

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

TL;DR: The effects of the endocannabinoid AEA on primary human T-lymphocytes are investigated for the first time, demonstrating that it is a powerful modulator of immune cell functions and clarified that CB2R mediates the immunosuppressive activity of AEA.